FDA is testing products originating from Pakistan that have reached the market in Nagpur, under the jurisdiction of Maharashtra.
Steady: 1 in the last 7 days
Updated friday
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA is testing products originating from Pakistan that have reached the market in Nagpur, under the jurisdiction of Maharashtra.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- DRAP ordered immediate nationwide ban on fake cancer medicines in Pakistan.Sub-event
FDA testing of products from Pakistan in the Nagpur market.1 source
Keep exploring
The entities involved
Related events
- FDA took action against facilities in Bhiwandi, inspected Khed warehouses, and found food safety violations at Reliance Retail in Pune.
- Ajay Devgn challenged a notice in the High Court while the FDA enforced state rules in Maharashtra.
- Granules India Limited is submitting ANDA and Paragraph IV certification to the FDA.
- The FDA (Q11200607) and the Food Safety and Standards Authority of India (Q5465383) are involved in a new development regarding the governance of inspections.
- The FDA suspended licenses and seized goods from a distributor associated with Patanjali Ayurved.